antibody

Documents about antibody

• Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies#234411ClinicalTrials.gov
• A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)#426762ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)#810834ClinicalTrials.gov
• Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination#858786ClinicalTrials.gov
• Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults#861752ClinicalTrials.gov
• SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast Cancer#865957ClinicalTrials.gov
• CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA#873668ClinicalTrials.gov
• A Single-Center, Single-Arm Study of Neoadjuvant Short-Course Radiotherapy With IL-2 Followed by Sequential Immunotherapy With CAPOX Combined With PD-1 Antibody and IL-2 for Locally Advanced Rectal Cancer#125841ClinicalTrials.gov
• Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of D#164844Unpaywall
• Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.#353335ClinicalTrials.gov
• First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial#428717S-Space: Seoul National University
• A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer#825503ClinicalTrials.gov
• Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAG#831229ClinicalTrials.gov
• The Italian Multiple Sclerosis and Related Disorders Register#838222ClinicalTrials.gov
• First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers#846458ClinicalTrials.gov
• SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)#850530ClinicalTrials.gov
• Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic Melanoma#861179ClinicalTrials.gov
• A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)#871024ClinicalTrials.gov
• Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases#883251ClinicalTrials.gov
• COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses#883405ClinicalTrials.gov
• Identification of biologically active peptides through innovative liquid chromatography–mass spectrometry technologies in self-recoverable protein materials to be developed into active ingredient#242038IRIS
• Controlling Rotavirus-associated diarrhea: Could single-domain antibody fragments make the difference? = Hacia el control de la diarrea por rotavirus A: ¿podrían los nanoanticuerpos VHH marcar la diferencia?#398913DSpace
• Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response#492009eScholarship
• Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers#634550Dipòsit Digital de la Universitat de Barcelona
• Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)#804034ClinicalTrials.gov
• PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice#808011ClinicalTrials.gov
• A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab#839044ClinicalTrials.gov
• A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs#839634ClinicalTrials.gov
• A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer#855003ClinicalTrials.gov
• Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody#202774IRIS
• Data Sheet 1_Influence of immune checkpoint inhibitor target and timing on combination treatment with antibody-based β-emitting targeted radionuclide therapy across tumor immunogenicity profiles.pdf#424557Figshare
• Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)#830801ClinicalTrials.gov
• A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer#831793ClinicalTrials.gov
• Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Mid-low Locally Advanced Rectal Cancer - a Single-center, Single-arm, Open-label Clinical Trail#180391ClinicalTrials.gov
• Detection of TrkB Receptors Distributed in Cultured Hippocampal Neurons through Bioconjugation between Highly Luminescent (Quantum Dot-Neutravidin) and (Biotinylated Anti-TrkB Antibody) on Neurons by Combined Atomic Force Microscope and Confocal Laser Scanning Microscope#326599KOASAS: KAIST Open Access Self-Archiving System
• Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment#612106eScholarship
• Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer Current Evidence and Evolving Considerations: JACC: CardioOncology Primer#675936eScholarship
• Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients#843873ClinicalTrials.gov
• Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis#847714ClinicalTrials.gov
• Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma#859051ClinicalTrials.gov
• Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors#876209ClinicalTrials.gov
• An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)#811242ClinicalTrials.gov
• Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients#813639ClinicalTrials.gov
• Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma#830418ClinicalTrials.gov
• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip#836846ClinicalTrials.gov
• A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1#847283ClinicalTrials.gov
• A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)#858998ClinicalTrials.gov
• Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.#873425ClinicalTrials.gov
• Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention#473062ODU Digital Commons
• Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability#620071eScholarship